Oncolytics Biotech Inc Share Price

NASDAQ: ONCY

Small Cap

$1.28

-0.03

(-2.38%)

as on September 13, 2025 at 1:29 am IST

$₹

Oncolytics Biotech Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$1.25
Day's Price Range
$1.33
$1.28
2.34%
Downside
3.91%
Upside
52 Week's Low
52 Week's High
$0.33
52-Week Price Range
$1.53
$1.28
74.55%
Downside
19.53%
Upside

Oncolytics Biotech Inc share price movements today

Previous Close: $1.31
Open: $1.31
Volume: 2.4M
Day's Low - High: $1.25 - $1.33
52 Week Low - High: $0.33 - $1.53

Oncolytics Biotech Inc Historical Returns

1 Month Return: + 18.52 %
3 Month Return: + 110.53 %
1 Year Return: + 33.89 %
3 Year Return: -1.54 %
5 Year Return: -25.58 %

Oncolytics Biotech Inc Stock Fundamentals & Key Indicators

Check Oncolytics Biotech Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$129.6M

EPS (TTM)

-0.283

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-30.9M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

18156000.00%

Oncolytics Biotech Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oncolytics Biotech Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Oncolytics Biotech Inc	BUY	$129.6M	-25.58%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Oncolytics Biotech Inc Stock including INR - Dollar returns

The Oncolytics Biotech Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Oncolytics Biotech Inc investment value today

Current value as on today

₹1,38,472

Returns

₹38,472

(+38.47%)

Returns from Oncolytics Biotech Inc Stock

₹33,333 (+33.33%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Oncolytics Biotech Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Oncolytics Biotech Inc. Average target price of $4.61

Oncolytics Biotech Inc Share Price Target

Get share price movements and forecasts by analysts on Oncolytics Biotech Inc.

What analysts predicted

72.23%UPSIDE

Target Price

$4.61

Current Price

$1.28

Analyzed by

11 Analysts

Target

$4.61

Oncolytics Biotech Inc target price $4.61, a slight upside of 72.23% compared to current price of $1.28. According to 11 analysts rating.

Oncolytics Biotech Inc Stock's Interest Amongst Investors

Search interest for Oncolytics Biotech Inc Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 16, 2025 to September 15, 2025

Change:-31% versus previous 30 day period

Oncolytics Biotech Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	-	-	-	-
Operating Income	-6	-7	-11	-8	-8	-7	-9	-8	-6	-5
EBITDA	-6	-7	-10	-8	-8	-7	-9	-8	-6	-5
Interest Expense	0	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-7	-9	-3	-6	-7	-9	-7	-6	-6
Income Tax Expense	0	0	0	0	0	0	0	0	-	0
Net Income	-4	-5	-7	-2	-5	-5	-7	-5	-4	-6
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Oncolytics Biotech Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	-
Operating Income	-13	-15	-15	-16	-20	-25	-26	-28	-33	-34
EBITDA	-13	-15	-15	-17	-20	-25	-25	-26	-33	-34
Interest Expense	-	-	-	-	-	-	0	0	-	-
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-13	-15	-15	-16	-33	-22	-26	-24	-27	-31
Income Tax Expense	0	0	0	0	12	-2	0	0	0	0
Net Income	-10	-11	-12	-12	-34	-15	-20	-18	-20	-22
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Oncolytics Biotech Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-7	-9	-3	-6	0	-9	-8	-6	-6
Operating Cash Flow	-8	-6	-6	-7	-6	-4	-7	-6	-5
Investing Cash Flow	6	6	0	0	0	0	0	-	-
Financing Cash Flow	3	21	1	1	1	0	3	5	5
Change in Cash	1	22	-4	-4	0	-5	-3	0	0

Oncolytics Biotech Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-15	-15	-17	-33	-22	-26	-24	-27	-31
Operating Cash Flow	-12	-14	-11	-19	-22	-22	-23	-28	-26
Investing Cash Flow	0	1	0	0	0	0	-20	20	0
Financing Cash Flow	0	12	13	21	39	33	12	31	6
Change in Cash	-11	0	1	0	17	10	-29	23	-18

Global Institutional Holdings in Oncolytics Biotech Inc

Funds	Holdings
International Assets Investment Management, LLC	0.21%
SEEDS INVESTOR LLC	0.2%
Goldman Sachs Group Inc	0.11%
Royal Bank of Canada	0.07%
Geode Capital Management, LLC	0.07%

See all

Insights on Oncolytics Biotech Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, ONCY stock has moved up by 110.5%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 125.0%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 41.7%

About Oncolytics Biotech Inc

oncolytics biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of cancers. the company is conducting clinical studies using reolysin®, its proprietary formulation of the human reovirus, in some of the most prevalent forms of the disease including lung, colorectal and pancreatic cancers. oncolytics’ clinical program includes a number of human trials at a variety of stages including a phase iii trial in head and neck cancers. the company has advanced its product manufacturing and intellectual property initiatives in parallel with its clinical development program to support development of a commercial product.

Organisation	Oncolytics Biotech Inc
Headquarters	322 11th Avenue SW, Calgary, AB, Canada, T2R 0C5
Industry	Health Technology
CEO	Mr. Jared Kelly J.D., L.L.M.
E-voting on shares	Click here to vote

Key Management of Oncolytics Biotech Inc

Name	Title
Ms. Allison Hagerman P.Eng., P.M.P.	Vice President of Product Development
Ms. Amy Goodowitz Levin B.S.N., R.N.	Vice President of Clinical Operations
Mr. Jared Kelly J.D., L.L.M.	CEO & Director
Jon Patton	Director of Investor Relations & Communication
Mr. Andrew P. Aromando	Chief Business Officer
Mr. John Mark Lievonen B.B.A., CM, F.C.A., FCPA, LLD, M.B.A.	Consultant
Mr. Kirk J. Look C.A., CPA	Chief Financial Officer
Dr. Thomas C. Heineman M.D., Ph.D.	Chief Medical Officer

FAQs

What is Oncolytics Biotech Inc share price today?

Oncolytics Biotech Inc share price today is $1.28 as on September 13, 2025 at 1:29 am IST at the close of the market. Oncolytics Biotech Inc share today touched a day high of $1.33 and a low of $1.25.

What is the 52 week high and 52 week low for Oncolytics Biotech Inc share?

Oncolytics Biotech Inc share touched a 52 week high of $1.53 on October 7, 2024 and a 52 week low of $0.33 on June 6, 2025. Oncolytics Biotech Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $1.28,which is 16.34% down from its 52 week high and 292.88% up from its 52 week low.

What is Oncolytics Biotech Inc's market capitalisation today?

Oncolytics Biotech Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Oncolytics Biotech Inc Stock (ONCY) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Oncolytics Biotech Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oncolytics Biotech Inc Shares that will get you 1.1719 shares as per Oncolytics Biotech Inc share price of $1.28 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Oncolytics Biotech Inc Stock (ONCY) from India?

Indian investors can start investing in Oncolytics Biotech Inc (ONCY) shares with as little as ₹88.27 or $1 (as of September 15, 2025 at 3:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Oncolytics Biotech Inc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 3:39 pm IST). Based on Oncolytics Biotech Inc share’s latest price of $1.28 as on September 13, 2025 at 1:29 am IST, you will get 7.8125 shares of Oncolytics Biotech Inc. Learn more about fractional shares .

What are the returns that Oncolytics Biotech Inc has given to Indian investors in the last 5 years?

Oncolytics Biotech Inc stock has given -25.58% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?